Trial reportSleep & breathing = Schlaf & Atmung2025
Nurse-managed telemonitoring in patients with sleep apnea syndrome treated with positive pressure ventilation.
Trial report in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeObstructive sleep apnea (OSA) is the commonest sleep disorder, it is characterized by episodes of complete or partial upper airway obstruction, sleep fragmentation and intermittent hypoxia (Am J Epidemiol 177:1006-14, 2013). Continuous Positive pressure ventilation (CPAP), is the gold standard treatment for Obstructive Sleep Apnoea Syndrome (OSAS). Several psycho-educational and technological interventions have been implemented to improve compliance but their impact on therapeutic adherence hasn't turned out to be substancial (Am J Respir Crit Care Med 159:1108-1114, 1999). Technological progress facilitated the use of tele-monitoring (TM) in OSAS patients (Eur Respir J 49:1601128, 2017). The use of TM, by trained nurses, improves compliance and allows for real-time adjustments to ventilatory parameters and correcting any therapeutic error. This can reduce the need for additional hospital visits and optimizes resources.
aimTo evaluate the differences in compliance, proper usage, number of visits, and overall efficacy/benefit during follow-up between two groups of OSAS patients treated with CPAP.
methodsA prospective, randomized controlled trial was conducted involving patients with OSAS treated with CPAP. Participants were randomized into two groups. Group 1 underwent standard follow-up visits at 1, 6, and 12 months. Group 2 was monitored via nurse-managed telemonitoring, which included monthly telephone contacts during the first six months, followed by contacts at 60-day intervals thereafter.
resultsNo significant differences were observed between Group 1 and Group 2 in terms of comfort, proper usage, and benefit from CPAP. However, Group 2 showed a reduction in hospital visits.
conclusionsOSAS patients under CPAP treatment can be effectively managed via telemonitoring, yielding results comparable to those obtained through traditional medical visits. The TM approach enables to postpone in-person visits optimizes the use of healthcare resources.
Indexed as
Identifiers
40738979What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.